T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.68B |
| 2 |
Eli Lilly
LLY
|
+$1.43B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
Tesla
TSLA
|
+$1.13B |
| 5 |
Wells Fargo
WFC
|
+$734M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$20.6B |
| 2 |
Microsoft
MSFT
|
+$5.74B |
| 3 |
Amazon
AMZN
|
+$3.33B |
| 4 |
Yum! Brands
YUM
|
+$2.6B |
| 5 |
Salesforce
CRM
|
+$2.35B |
Sector Composition
| 1 | Technology | 26.11% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
EPAM Systems
EPAM
$8.53B
| $54.5M | 0.01% |
150,380
-28,360
| -16% | -$10.3M |
|
627
Novanta
NOVT
$4.14B
| $54M | 0.01% |
467,320
-1,620,122
| -78% | -$187M |
|
|
BHVN
628
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $53.9M | 0.01% |
356,257
-165,323
| -32% | -$25M |
|
|
LTHM
629
DELISTED
Livent Corporation
LTHM
| $53.4M | 0.01% |
1,742,535
+408,249
| +31% | +$12.5M |
|
630
Cytokinetics
CYTK
$6.22B
| $53M | 0.01% |
1,093,447
+595,708
| +120% | +$28.9M |
|
631
Watsco
WSO
$15.8B
| $52.5M | 0.01% |
203,952
-64,868
| -24% | -$16.7M |
|
632
Immuneering
IMRX
$338M
| $52.5M | 0.01% |
3,663,492
-479,337
| -12% | -$6.86M |
|
633
Blue Owl Capital
OWL
$12.1B
| $52.4M | 0.01% |
5,672,724
+305,780
| +6% | +$2.82M |
|
634
Delta Air Lines
DAL
$40.1B
| $52.3M | 0.01% |
1,863,984
+251,480
| +16% | +$7.06M |
|
|
CHX
635
DELISTED
ChampionX
CHX
| $52.2M | 0.01% |
2,668,246
-4,536,737
| -63% | -$88.8M |
|
636
Globus Medical
GMED
$7.89B
| $51.9M | 0.01% |
871,758
+5,267
| +0.6% | +$314K |
|
637
BioMarin Pharmaceuticals
BMRN
$10.5B
| $51.9M | 0.01% |
611,707
+86,888
| +17% | +$7.37M |
|
|
DICE
638
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $51.8M | 0.01% |
2,553,457
+138,833
| +6% | +$2.82M |
|
|
DHR.PRB
639
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
| – | – |
-38,279
| Closed | -$51.2M |
|
640
Clean Harbors
CLH
$12.6B
| $51M | 0.01% |
463,901
+45,140
| +11% | +$4.96M |
|
|
IGMS
641
DELISTED
IGM Biosciences
IGMS
| $50.4M | 0.01% |
2,217,766
-405,107
| -15% | -$9.21M |
|
642
Iridium Communications
IRDM
$1.91B
| $50.3M | 0.01% |
1,133,727
+24,100
| +2% | +$1.07M |
|
643
Phillips 66
PSX
$53.1B
| $50.3M | 0.01% |
622,799
-337
| -0.1% | -$27.2K |
|
644
Merit Medical Systems
MMSI
$5.26B
| $50.1M | 0.01% |
886,190
+2,344
| +0.3% | +$132K |
|
645
QuidelOrtho
QDEL
$1.88B
| $49.8M | 0.01% |
697,068
-6,948,213
| -91% | -$497M |
|
646
Akero Therapeutics
AKRO
$3.46B
| $49.8M | 0.01% |
1,462,424
+1,007,122
| +221% | +$34.3M |
|
647
Wendy's
WEN
$1.87B
| $49.7M | 0.01% |
2,661,751
+23,127
| +0.9% | +$432K |
|
648
Public Service Enterprise Group
PEG
$40.8B
| $49.7M | 0.01% |
883,241
-1,273,548
| -59% | -$71.6M |
|
649
Newmont
NEM
$86.2B
| $49.5M | 0.01% |
1,178,531
+152,879
| +15% | +$6.43M |
|
650
Warner Bros
WBD
$31B
| $49.1M | 0.01% |
4,265,787
-176,700
| -4% | -$2.03M |
|